Development by UCLA-led research team works to keep blood sugar at normal levels
UCLA bioengineers and their colleagues have developed a new type of insulin that could help prevent hypoglycemia in people who use the drug to manage diabetes.
The treatment is being evaluated for potential clinical trials and, if successful, could change diabetes care. The study was published in the Proceedings of the National Academy of Sciences.
Insulin is a hormone naturally produced in the pancreas. It helps the body regulate glucose, which is consumed through food and provides the body with energy.
Diabetes occurs when a person’s body does not naturally produce insulin (Type 1 diabetes), or does not efficiently use the insulin that is produced (Type 2). In either case, a regular dosage of insulin is prescribed to manage the disease, which affects more than 400 million people worldwide.
Generally, people who need to use insulin monitor their blood sugar levels with a glucose meter or continuous glucose monitoring system and then calculate their insulin dose accordingly. In addition, a regular carbohydrate intake is important to keep the blood sugar levels normal. Both of these requirements are necessarily subject to human error, which can have potentially devastating consequences.
An overdose of insulin can cause hypoglycemia, when blood sugar is too low. That could lead to seizures, coma, and in extreme cases, death.
As a safety check, the UCLA-led team has developed a type of “smart” insulin, called i-insulin, that can prevent blood sugar levels from dipping too low.
Inside the body, insulin acts as a “key” to help glucose get into cells from the bloodstream. When insulin attaches to a cell’s surface, it activates a protein inside the cell, called glucose transporter, which then makes its way to the cell’s surface. This molecule then brings the surrounding glucose from the blood into the cell.
The research team added an additional molecule to insulin to create the new smart insulin. This added molecule, called a glucose transporter inhibitor, chemically blocks the glucose transporter molecule that has come to the surface. Its presence doesn’t block all glucose from entering, nor does it permanently block the transporter molecules. Instead, it’s part of a dynamic process that depends on how many inhibitor and glucose molecules are present.
“Our new i-insulin works like a ‘smart’ key,” said the study’s principal investigator Zhen Gu, a professor of bioengineering at the UCLA Samueli School of Engineering. “The insulin lets glucose get into the cell, but the added inhibitor molecule prevents too much from going in when blood sugar is normal. This keeps blood sugar at normal levels and reduces the risk of hypoglycemia.”
“This i-insulin can also rapidly respond to high glucose levels,” added Jinqiang Wang, the study’s co-lead author and a postdoctoral researcher in Gu’s research group. “For example, after a meal, when glucose levels climb, the insulin level in the bloodstream also quickly increases, which helps normalize the glucose level.”
The UCLA-led research team tested the smart insulin on mice with Type 1 diabetes. The i-insulin controlled glucose levels within the normal range for up to 10 hours after a first injection. A second injection three hours later extended the protection from hypoglycemia.
“The next step is to further evaluate the long-term biocompatibility of the modified insulin system in an animal model before determining whether to move to clinical trials,” said co-author Dr. John Buse, a professor and director of the Diabetes Care Center at the University of North Carolina School of Medicine. “The vision, if realized, would be one of the most exciting advances in diabetes care.”
“The new insulin has the potential to be optimized for response times and how long it could last in the body before another dose would be required,” Gu said. “And it could be delivered in other methods, such as a skin patch with tiny needles, or in pills.”
The Latest on: Diabetes
via Google News
The Latest on: Diabetes
- Why is type-2 diabetes on the rise?on November 29, 2019 at 7:42 pm
The increase in type 2 diabetes is fuelled in part by rising obesity rates. © Getty Images Diabetes can develop at any age, but there are factors which put some at particular risk. Many of us follow a ...
- Around the Diabetes Online Community: November 2019on November 29, 2019 at 2:59 am
Here we are wrapping up another November, National Diabetes Awareness Month. This year's awareness month has been as prolific as ever, with some hot topics brewing across the community. Please enjoy ...
- Know these five diabetes warning signson November 29, 2019 at 2:00 am
In a post that has more than 1 million likes, singer Nick Jonas recently took to Instagram to reflect on the 14-year anniversary of his Type 1 diabetes diagnosis and shared how the disease has ...
- FDA seeks to clear hurdles for biosimilar insulin in attempt to cut costs for diabetes patientson November 28, 2019 at 10:31 am
The Food and Drug Administration has been quietly paving the way to bring a cheaper type of insulin to market — an effort that could improve access to lifesaving medication for millions of Americans ...
- How to navigate holiday meals and stay healthy when you have diabeteson November 28, 2019 at 6:45 am
The winter holidays can be a time of joy and family togetherness, but they have the potential to be stressful and challenging, especially for people with diabetes. Navigating festive meals while ...
- Digital Diabetes Management Gains Momentum: 3 Stocks in Focuson November 28, 2019 at 5:14 am
The alarming rise in cases of diabetes globally has prompted the National Institute of Health (NIH) to tag it as the biggest epidemic of the 21st century. Going by the figures published by the ...
- Sharing Diabetes Thoughts on Thanksgivingon November 28, 2019 at 3:25 am
Of course, there's never a day off when it comes to living with diabetes. So we have to get clever about managing our "manual transmission" pancreases in the face of holiday feasts. We asked around ...
- Gut microbes may predict whether exercising will prevent diabeteson November 27, 2019 at 8:07 am
That is according to research showing how people with certain microbiomes have better metabolic outcomes after exercise. The discovery opens the door to diabetes treatments that target the microbes in ...
- Link Found Between Gender Dysphoria and Type 1 Diabeteson November 27, 2019 at 7:50 am
Youth with gender dysphoria may be at increased risk for developing type 1 diabetes, new observational research suggests. The study of more than 2000 individuals aged 10 to 21 years at a single ...
- Legislation targeting the ‘skyrocketing’ cost of diabetes medicine passed by state legislatureon November 26, 2019 at 10:38 pm
[Most read] Heart transplant patient with possibly days left to live weds high school sweetheart in Chicago hospital chapel » The cost of diabetes medicine has been viewed as especially egregious by ...
via Bing News